1. Home
  2. DDD vs OABI Comparison

DDD vs OABI Comparison

Compare DDD & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 3D Systems Corporation

DDD

3D Systems Corporation

HOLD

Current Price

$1.93

Market Cap

285.8M

Sector

Technology

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$2.17

Market Cap

239.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDD
OABI
Founded
1986
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
285.8M
239.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DDD
OABI
Price
$1.93
$2.17
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$4.75
$6.67
AVG Volume (30 Days)
2.9M
571.9K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$391,651,000.00
$21,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.31
$66.19
P/E Ratio
$18.14
N/A
Revenue Growth
N/A
3.36
52 Week Low
$1.32
$1.22
52 Week High
$5.00
$4.08

Technical Indicators

Market Signals
Indicator
DDD
OABI
Relative Strength Index (RSI) 40.69 73.35
Support Level $1.70 $1.90
Resistance Level $2.29 $2.04
Average True Range (ATR) 0.12 0.11
MACD 0.01 0.04
Stochastic Oscillator 38.14 88.68

Price Performance

Historical Comparison
DDD
OABI

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: